Viking Therapeutics Unusual Options Activity For June 25
Viking Therapeutics Unusual Options Activity For June 25
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $15.0 to $70.0 for Viking Therapeutics during the past quarter. High-rolling investors have positioned themselves bullish on Viking Therapeutics (NASDAQ:VKTX), and it's important for retail traders to take note.\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in VKTX often signals that someone has privileged information.
大股东看好Viking Therapeutics (纳斯达克:VKTX)，我们建议个人投资者关注。这一行动是通过Benzinga对公开可用期权数据的跟踪而引起我们的注意的。这些投资者的身份不确定，但VKTX出现如此重要的变动通常意味着某些人持有特权信息。
Today, Benzinga's options scanner spotted 8 options trades for Viking Therapeutics. This is not a typical pattern.
今天，Benzinga的期权扫描器发现了8笔Viking Therapeutics的期权交易，这并不是一种典型的模式。
The sentiment among these major traders is split, with 87% bullish and 0% bearish. Among all the options we identified, there was one put, amounting to $56,000, and 7 calls, totaling $414,979.
这些主要交易者的情绪分裂，其中87%看涨，0%看跌。我们所确定的所有期权中有一种看跌期权，金额为56,000美元，以及7种看涨期权，总金额为414,979美元。
What's The Price Target?
价格目标是什么？
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $15.0 to $70.0 for Viking Therapeutics during the past quarter.
分析这些合同的成交量和未平仓合约，似乎大户在过去的季度中一直注视着15.0到70.0美元之间的Viking Therapeutics价格区间。
Volume & Open Interest Trends
成交量和未平仓量趋势
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Viking Therapeutics's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Viking Therapeutics's whale trades within a strike price range from $15.0 to $70.0 in the last 30 days.
在期权交易中查看成交量和未平仓合约是重要的一步。这些数据可以帮助您追踪给定行权价的Viking Therapeutics期权的流动性和关注度。下面，我们可以观察Viking Therapeutics的所有鲸鱼交易中，在15.0到70.0美元行权价区间内看涨期权和看跌期权的成交量和未平仓合约的变化情况。
Viking Therapeutics Option Volume And Open Interest Over Last 30 Days
Viking Therapeutics过去30天内期权成交量和未平仓合约变化情况
Significant Options Trades Detected:
检测到重大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | CALL | TRADE | BULLISH | 07/19/24 | $1.6 | $1.6 | $1.6 | $60.00 | $136.0K | 2.0K | 596 |
| VKTX | CALL | TRADE | BULLISH | 01/17/25 | $36.1 | $34.9 | $36.1 | $15.00 | $90.2K | 714 | 1 |
| VKTX | PUT | TRADE | BULLISH | 01/17/25 | $5.9 | $5.6 | $5.6 | $37.00 | $56.0K | 53 | 6 |
| VKTX | CALL | SWEEP | BULLISH | 01/16/26 | $29.0 | $27.5 | $29.0 | $30.00 | $55.1K | 351 | 2 |
| VKTX | CALL | SWEEP | BULLISH | 07/19/24 | $1.45 | $1.3 | $1.45 | $60.00 | $41.6K | 2.0K | 1.5K |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | 看涨 | 交易 | 看好 | 07/19/24 | $1.6 | $1.6 | $1.6 | $60.00 | $136.0K | 2.0K | 596 |
| VKTX | 看涨 | 交易 | 看好 | 01/17/25 | $36.1 | $34.9 | $36.1 | 15.00美元 | 90.2K | 714 | 1 |
| VKTX | 看跌 | 交易 | 看好 | 01/17/25 | $5.9 | $5.6 | $5.6 | $37.00 | $56.0K | 53 | 6 |
| VKTX | 看涨 | SWEEP | 看好 | 01/16/26 | $29.0 | $27.5 | $29.0 | $30.00 | $55.1K | 351 | 2 |
| VKTX | 看涨 | SWEEP | 看好 | 07/19/24 | $1.45 | $1.3 | $1.45 | $60.00 | $41.6千 | 2.0K | 1.5K |
About Viking Therapeutics
关于Viking Therapeutics
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Viking Therapeutics Inc是一家卫生服务提供商，专门从事代谢和内分泌障碍领域的生物制药开发。该公司的临床项目流水线包括VK2809、VK5211、VK0214产品。VK2809和VK0214是口服、组织和受体亚型选择性的甲状腺激素受体β激动剂。VK5211是一种口服、非类固醇选择性雄激素受体调节剂。
Following our analysis of the options activities associated with Viking Therapeutics, we pivot to a closer look at the company's own performance.
在分析与Viking Therapeutics相关的期权交易活动后，我们转而更近距离地关注该公司的业绩表现。
Where Is Viking Therapeutics Standing Right Now?
Viking Therapeutics现状如何？
- Trading volume stands at 1,066,972, with VKTX's price up by 0.17%, positioned at $52.21.
- RSI indicators show the stock to be may be oversold.
- Earnings announcement expected in 29 days.
- 交易量为1,066,972，VKTX价格上涨0.17%，位于52.21美元。
- RSI指标显示该股票可能已被超卖。
- 预计29天内公布收益。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Viking Therapeutics with Benzinga Pro for real-time alerts.
交易期权涉及更大的风险，但也提供了更高的利润潜力。精明的交易者通过持续教育、战略性的交易调整、利用各种因子和保持市场动态来减轻这些风险。使用Benzinga Pro即可了解Viking Therapeutics的最新期权交易情况，并获取实时警报。
